Financial analysis · adoption-ready estimate

Deal Tracker ·

If an entrepreneur "adopted" this product today, here's the realistic math.

Fermi summary

If you grind to 120 paying teams at $60/month that's $86k ARR - but with a 13% shot at getting there and $29k in the ground first, expect year 1 to cost you money, not make it.

Market size (TAM)

$240.0M

~480k US SMBs with 2-25 person sales teams actively managing a pipeline × ~$500/year avg spend on pipeline/CRM tooling

Year-1 ARR range

$14k - $252k

midpoint $86k

Gross margin

76%

Investment to production

$29k

Dev: $13k for CRM data import (CSV/HubSpot/Pipedrive), auth, billing, and AI deal-health scoring logic. Marketing: $10k for outbound to sale

Probability of success

13%

P(reaching mid case in 12 months)

Expected take-home Y1

$-17473

probability-weighted, after investment

Go-to-market motion

Outbound LinkedIn/cold email to VP Sales and sales managers at 10-50 person companies → demo → free 14-day trial → $59/month conversion; target 8 new customers/month by month 9.

Key risks

CRM fatigue: Salesforce Einstein, HubSpot Breeze, and Pipedrive AI all added pipeline AI in 2024-2025 - the incumbents already own the dataset and the relationship, making 'AI deal tracking' a feature not a product for most buyers.
Non-adoption churn: pipeline tools die when sales reps stop logging deals; without CRM enforcement or integrations that auto-pull data, churn at 6-month mark is brutal (40-60% annual in this category).
Integration dependency: if the product requires manual data entry instead of syncing from Salesforce/HubSpot, conversion from trial to paid collapses - building reliable two-way sync is expensive and ongoing.

Generated by the Wishdeal Factory financial-analysis agent. Numbers are honest Fermi estimates, not guarantees. Real outcomes depend on the operator. The studio is bullish on the engineering quality, agnostic on the business outcome.